Stockreport

Excalipoint debuts with $68.7m to progress TCE pipeline [Yahoo! Finance]

NovaBridge Biosciences - American Depositary Shares  (NBP) 
PDF engager (TCE) therapies in immunology and oncology as it emerges with $68.7m in seed funding under its wing. Excalipoint, which operates under a NewCo model, obtained [Read more]